Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis

被引：0
|
作者：
Deodhar, Atul [1 ]
Blauvelt, Andrew [2 ]
Schwartzman, Sergio [3 ]
Salvarani, Carlo [4 ]
Feely, Meghan [5 ]
Kronbergs, Andris [5 ]
Eberhart, Nadia [6 ]
Zhu, Danting [5 ]
Mevel, Elsa [5 ]
Holzkamper, Thorsten [5 ]
Krishnan, Eswar [7 ]
Lebwohl, Mark [8 ]
Rahman, Proton [9 ]
Marzo-Ortega, Helena [10 ,11 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] Oregon Med Res Ctr, Portland, OR USA
[3] 72Nd St Med Associates, Scarsdale, NY USA
[4] Univ Reggio Emilia, Reggio Emilia, Italy
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] Eli Lilly & Co, Vienna, Austria
[7] Eli Lilly & Co, Carmel, IN USA
[8] Icahn Sch Med Mt Sinai, New York, NY USA
[9] Mem Univ, St John, NF, Canada
[10] Leeds Teaching Hosp Trust, Leeds, England
[11] Univ Leeds, Leeds, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1042
引用
收藏
页码：2071 / 2074
页数：4
相关论文
共 50 条
  • [21] Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials
    Curtis, Jeffrey R.
    Mariette, Xavier
    Gaujoux-Viala, Cecile
    Blauvelt, Andrew
    Kvien, Tore K.
    Sandborn, William J.
    Winthrop, Kevin
    de Longueville, Marc
    Huybrechs, Ivo
    Bykerk, Vivian P.
    RMD OPEN, 2019, 5 (01):
  • [22] Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
    Ciurea, Adrian
    Gotschi, Andrea
    Kissling, Seraphina
    Bernatschek, Alexander
    Burki, Kristina
    Exer, Pascale
    Nissen, Michael J.
    Moller, Burkhard
    Scherer, Almut
    Micheroli, Raphael
    RMD OPEN, 2023, 9 (02):
  • [23] An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis treated with ixekizumab from 26 clinical studies
    Schwartzman, Sergio
    Puig, Luis
    Cohen, Arnon D.
    Khattri, Saakshi
    Jossart, Christian
    Diaz, Carlos
    Garrelts, Alyssa
    Zhu, Danting
    Eberhart, Nadezhda
    Eleftheriadi, Areti
    Tangsirisap, Nithi
    Schuster, Christopher
    Gottlieb, Alice B.
    Sheesh, Mohamed
    RHEUMATOLOGY, 2024, 63
  • [24] Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
    Pombo-Suarez, Manuel
    Seoane-Mato, Daniel
    Diaz-Gonzalez, Federico
    Cea-Calvo, Luis
    Sanchez-Alonso, Fernando
    Sanchez-Jareno, Marta
    Jovani, Vega
    Garcia-Magallon, Blanca
    Martinez-Gonzalez, Olga
    Campos-Fernandez, Cristina
    Manero, Javier
    Diaz-Torne, Cesar
    Bohorquez, Cristina
    Ros-Vilamajo, Inmaculada
    Perez-Vera, Yanira
    Castrejon, Isabel
    MUSCULOSKELETAL CARE, 2023, 21 (01) : 189 - 197
  • [25] Safety Profile of Ixekizumab for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis Up to 3 Years: an Updated Integrated Safety Analysis
    Schwartzman, Sergio
    Deodhar, Atul
    Combe, Bernard
    Accioly, Ana
    Kronbergs, Andris
    Janos, Boris
    Zhu, Danting
    Sandoval, David
    Rahman, Proton
    Poddubnyy, Denis
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 828 - 828
  • [26] Ixekizumab and Pregnancy Outcomes in Patients with Psoriasis or Psoriatic Arthritis
    Egeberg, Alexander
    Kimball, Alexa B.
    Feldman, Steven R.
    Riedl, Elisabeth
    Gallo, Gaia
    Agada, Noah
    Xu, Wen
    Iversen, Lars
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
  • [27] Ixekizumab and pregnancy outcomes in patients with psoriasis or psoriatic arthritis
    Egeberg, A.
    Feldman, S. R.
    Riedl, E.
    Gallo, G.
    Agada, N.
    Xu, W.
    Iversen, L.
    Norman, J.
    Raniga, J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 100 - 101
  • [28] Safety Profile of Ixekizumab for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis up to 3 Years: An Updated Integrated Safety Analysis
    Schwartzman, Sergio
    Deodhar, Atul
    Combe, Bernard
    Accioly, Ana
    Kronbergs, Andris
    Janos, Boris
    Zhu, Danting
    Calderon, David Sandoval
    Rahman, Proton
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3820 - 3823
  • [29] SAFETY PROFILE OF IXEKIZUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS UP TO 3 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Tay, Tien
    Schwartzman, Sergio
    Deodhar, Atul
    Combe, Bernard
    Accioly, Ana
    Kronbergs, Andris
    Janos, Boris
    Zhu, Danting
    Sandoval, David
    Rahman, Proton
    Poddubnyy, Denis
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 42 - 42
  • [30] COVID-19 in psoriasis, psoriatic arthritis, and axial spondyloarthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (04): : E182 - E182
12345